EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NVAX) Is Up 6.3% After Activist Sale Push and Sanofi-Focused Royalty Pivot - What's Changed - Simply Wall St News
Novavax (NVAX): Weighing Undervaluation Claims Against Fading Momentum and DCF Signals
Evaluating Novavax's Current Valuation After Steep Five Year Share Price Collapse
Novavax (NVAX) Valuation Check as FDA Scrutiny Rises and Activist Pushes for Possible Sale
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages
Novavax, Inc. (NVAX): A Bull Case Theory
Novavax (NVAX): Exploring Valuation After Prolonged Share Price Weakness
Is Novavax Now a Bargain After a 94.1% Five Year Share Price Slump?
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino
Novavax (NVAX) Valuation: Assessing the Shift to Partnerships and an R&D-Focused Strategy - Simply Wall St News
Novavax call volume above normal and directionally bullish | Markets Insider
What Recent Partnership Efforts Mean for the Value of Novavax in 2025
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
